Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).

Authors :: Takeda Y
Sakuma I
Hiramitsu S
Okada M
Ueda S
Sakurai M
Source :: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Mar 16; Vol. 10, pp. 1172664. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).
Publication Year :: 2023
Abstract: [This corrects the article DOI: 10.3389/fcvm.2023.1094100.].<br /> (© 2023 Takeda, Sakuma, Hiramitsu, Okada, Ueda and Sakurai.)

Full Text Access

Tools